THE 2019 Translational Research Symposium

Science communication: Talk Science to me
 
Translational Research Symposium 2018

The 7th Annual Translational Research Symposium will be held on Monday 5th and Tuesday 6th August at the Translational Research Institute, Brisbane. This year the theme is “Talk Science to Me” with the goal to encourage researchers to communicate their work with all types of audiences.  The 2019 categories to enter are Discover, Develop and Deliver.  These terms broadly describe the translational research pathway. 

This event promotes networking throughout South-East Queensland amongst post-graduate students and professionals willing to showcase their translational research. Oral and poster sessions will be held throughout the day.  All researchers and students are welcome to attend.

For more information please follow us on twitter @2019TRS and or contact the committee via email at [email protected]

 
 
Translational Research Symposium 2018
 

Download the Event Program booklet [PDF 8mb]

PRELIMINARY SYMPOSIUM PROGRAM

Monday 5th August 

Activity Time
Registration (Outside Auditorium) 11:00am
Welcome Address and Housekeeping 12:00pm
Special Guest Keynote Speaker: Nasim Amiralian 12:15pm
Lunch 1:00pm
Oral Session 1 1:45pm
Afternoon tea 3:00pm

Special Guest Discussion Panel: Talk Science to Me, Panellists:

Madeline Kersting Flynn, Carl Smith, Alison Rice and Jesse Thomas

3:30pm
Networking, Drinks and Nibbles 5:00pm

 

Tuesday 6th August 

Activity Time
Registration (Outside Auditorium) 8:00am
Welcome Address and Housekeeping 8:45am
Two Minute Tease Talks 9:00am
Morning tea (continued through Poster Session 1) 9:30am
Poster Session 1 9:30am
Oral Session 2 10:45am
Two Minute Tease Talks 12:00pm
Lunch (continued through Poster Session 2) 12:30pm
Poster Session 2 12:30pm
Talk Science to Me - Science Communication Prize (8 Speakers) 1:45pm
Afternoon Tea (continued through Poster Session 3) 2:45pm
Poster Session 3 2:45pm
Special Guest Keynote Speaker: Ken Dutton-Regester 4:00pm
Awards Ceremony and Close 4:45pm

Note: Catering is provided for all attendees, presenters, special guests, sponsors. Please register for catering purposes.

REGISTER NOW

DISCOVER

Investigate the what, why and how behind biological processes through fundamental research and proof of concept work

DEVELOP

Improve and design treatments, technologies, detection and delivery systems that would enable the fundamental research to be translated into a pre-clinical setting

DELIVER

Optimize and commercialize diagnosis, prognosis and treatments of preventative approaches in the clinical setting

Special Guest Discussion Panel - Monday August 5th, 3:30pm

 

SPECIAL GUEST DISCUSSION PANEL

3:30pm - 5:00pm

Monday 5th August

TRI Auditorium

 

MADELINE KERSTING FLYNN

Biomedical illustrator, QIMR

Madeleine Kersting Flynn has been a biomedical illustrator for over 23 years, and has been at her current position at QIMR Berghofer for the past 12 years. She specialises in both scientific and medical illustration, creating for researchers and clinicians. Traditionally trained, she has also adopted 3D modelling and animation techniques as new technology advances in the field, and is now expanding into more experimental ways of communicating science and medicine for a mainstream audience. 

She is a devoted advocate of science communication and education, and is the President of the Queensland Chapter of the Australian Institute of Medical and Biological Illustrators. She has organised workshops on biomedical illustration at the Queensland Museum, World Science Festival and the UQ School of Medicine.

Currently she is writing scripts for a children's show "Worms and Germs", which she hopes to launch in 2020. Future plans also include creating large-scale immersive environments and sculpture to achieve her goal of bringing science and medicine to the masses in an engaging and entertaining way.

CARL SMITH

ABC Science Journalist

Carl is a Walkley Award-winning science journalist and kids’ presenter at the ABC, working for RN and ABC Science. He makes radio documentaries for RN’s science programs, The Science Show, The Health Report, All in the Mind, and Science Friction. He also co-presents the kids’ podcasts Short & Curly and Pickle.

 

Before joining the ABC, Carl worked briefly as a scientist and ran the University of Queensland’s student radio station. In 2014 he moved to Canberra to train as an ABC News cadet, and in 2015 he joined the ABCME program Behind the News as a reporter.

 

He presented the ABCTV series Minibeast Heroes, and has collaborated with the BBC and WNYC on stories. Carl has won multiple awards for his work, including a Young Walkley Award in 2017, 'Young Journalist of the Year 2015' from the SA Press Club, 'Best New Australian Journalist 2014' from the Lizzies Tech Journalism Awards, and two Queensland Clarion Awards.

ALISON RICE

Deputy Leader, Synthetic Biology Future Science Platform, CSIRO

Dr Alison Rice has a Bachelor of Science with Honours from the University of Adelaide and a PhD in biological sciences from the University of Bordeaux II in France. She has worked as a 

senior research scientist leading research groups focused on new therapeutic options for the complications of haematopoietic stem cell transplantation in Medical Research Institutes in Sydney and Brisbane respectively.

 In 2012, she made the successful transition to a career in research development, incorporating research policy, research management and business development at Griffith University. In 2018 she took up a role as a Principal Policy Officer in the Health Innovation, Investment and Research Office (HIIRO; Queensland Health). She has drawn on her experience as a research scientist and research development expert to bring content specific knowledge about research, researchers and the research sector to the government sector. 

Her experience in medical research, the higher education sector and government has provided me with experience in strategy development and execution, leading and managing complex projects and teams, knowledge creation, data analysis and the opportunity to engage with and develop meaningful relationships with stakeholders; all of which are essential for her current role as Deputy Director, Synthetic Biology Future Science Platform at CSIRO.

JESSE THOMAS

Program Manager- Patheon

Dr Jesse Thomas completed his PhD in Molecular Biology & Immunology through the University of Melbourne and CSIRO in Therapeutic Innovation for Animal Health. Understanding early on that academia was not for him, he transitioned to private industry where, following a brief stint in Protein Purification R&D with CSL, he moved to a Drug Screening position at Biota Holdings in pre-clinical Hep C drug development. Managing lab scale drug screening, data generation / analysis and reporting results that directed the business to management, this role reinforced the criticality of soft skills and human interaction. Skills that have been a pillar for success in his career since. 

A strategic career change took him from lab work to full-scale commercial production of opiate derived Narcotic Raw Material within GSK and understanding how science runs as a business. An understanding of yield, throughput, and cost are at the heart of a Technical Experts role in a production environment. Designing, implementing and imbedding novel value adding processes with multi-faceted teams was an enjoyable and fulfilling challenge as Process Owner.

Now, as a Program Manager at Patheon, part of ThermoFisher Scientific in Brisbane, he contracts manufacture clinical trial biologics as per cGMP for small – medium sized biotech companies around the globe. With customer facing responsibilities, managing project finance, timelines and teams he finds himself even further from my distant technical base. 

At the core of my being he firmly believes in work / life balance, sharing wisdom, being bold, enjoying the journey and treating others well.

DAVID PENNISI

Dr David Pennisi received postgraduate training in molecular genetics in the Department of Biochemistry, The University of Queensland, and was awarded a PhD in 2000, receiving a Dean’s Commendation, School of Postgraduate Studies, for outstanding PhD thesis. He then undertook postdoctoral training in the area of heart development in the laboratory of Prof. Takashi Mikawa, Department of Cell and Developmental Biology, Cornell University Medical College, New York, NY, USA. He then returned to conduct research on kidney and heart development at the Institute for Molecular Bioscience, The University of Queensland. From 2011-2014 he held an academic position in the School of Biomedical Sciences, The University of Queensland, running a research group focused on cardiovascular development and acting as coordinator for undergraduate and Honours courses. He joined the Translational Genomics Group, QUT at Translational Research Institute, in 2016 as a science writer. 

Dr David Pennisi acts as a project manager for the Translational Genomics Group’s involvement in the Queensland Genomics Health Alliance (QGHA) and other projects. In this role, he coordinates and manages activities in the group and by external team members associated with the QGHA clinical demonstration project to incorporate genomics to the management of lung cancer in Queensland. He also acts as a science writer for the Genomics group, contributing to the preparation of research articles and grant applications.

.

 

DO YOU HAVE A QUESTION FOR THE SPECIAL GUESTS AT TRS 2019?

CLICK HERE TO SEND IT THROUGH!

Special Guest Keynote Speakers - Monday August 5th, 12:15pm, Tuesday August 6th, 4:00pm

SPECIAL GUEST KEYNOTE SPEAKERS

TRI Auditorium

NASIM AMIRALIAN

12:15pm - 1:00pm - Nasim Amiralian

Monday 5th August

UQ Amplify Research Fellow, Australian Institute of Bioengineering and Nanotechnology, University of Queensland

Dr Nasim Amiralian specialises in processing and structure-property performance of novel materials, renewable-based polymers and nanocomposites.

During her PhD, she discovered and patented a unique high-quality nanocellulose from spinifex, an Australian native arid grass, using simpler and more environmentally friendly methods. The outcome of her PhD project has resulted establishment of Australia’s first nanocellulose pilot production plant. Building on her innovations in spinifex nanocellulose, she is utilising the unique properties of nanocellulose to produce novel conductive hydrogel systems which could lead to improved conductive hydrogel technology.

In recognition of her contribution to the field of nanomaterials engineering and research excellence she has received a number of awards including; one of Australia’s Top 5 Scientists (ABC/UNSW, 2018), Queensland Women in STEM Prize- judges choice award (2017) and Women in Technology Life Sciences and/or Infotech Rising Star Award (2016).

KEN DUTTON-REGESTER

4:00pm - 4:45pm 

Tuesday 6th August

 Research Officer and QLD Tall Poppy Scientist, QIMR Berghofer Medical Research Institute

Affectionately known as ‘The Funky Dr’, Dr Ken Dutton-Regester is a Research Officer at the QIMR Berghofer Medical Research Institute exploring functional genomics in melanoma. After completing his PhD at the Queensland University of Technology in 2012, Ken was awarded a NHMRC Early Career Fellowship to learn genome-wide functional approaches at the Broad Institute of Harvard MIT and Dana Farber Cancer Institute.Ken returned to QIMR Berghofer in 2016 and is continuing his research into drug resistance mechanisms and novel drug targets in melanoma. He is an AMP Tomorrow Fund fellow, a Young Investigator on a Melanoma Research Alliance Team Science Award, and a past-chairperson of the Associate Member Council for the American Association for Cancer Research.  

 

Besides his research, Ken is extremely passionate about science communication. A national finalist in Famelab and a ‘Queensland Young Tall Poppy Scientist’ Awardee in 2017, Ken has spoken at a variety events including Pint of Science, Science Nation, Melanoma March, and the ‘Wonder of Science’ Flying Scientist program. Ken has explored unique ways to communicate his research including ‘full body poses’ to talk about different melanoma subtypes, UV cameras to demonstrate how sunscreen works and in 2018 entered the Science ‘Dance your PhD’ competition. On his latest venture, Ken is embarking on a new science education and outreach project to create the world’s first cancer-themed Puzzle Room (escape room) that will launch in National Science Week 2019.

 

List of Presenters (Oral, Poster and Two-Minute Tease Talks, Science Communication Talks and Translational Relevance Prize Shortlist)

 

ALL PRESENTERS MUST REGISTER

REGISTER NOW

Oral Presentations

Oral presentations will be 8 minutes, followed by 2 minutes question time per speaker. The winner and runner-up will be announced at the Award Ceremony on the 6th of August.  All presenters are required to attend the Award Ceremony.

AUDITORIUM

Guidelines and Categories for all Presentation types section of the website for more information

***Slides for this session need to be sent to [email protected] by 5pm, Thursday 1st August.***

Presenter

Title

Session

Rachel Colbran (On behalf of Monica Ding)

The effect of transvaginal prolapse surgery on anorectal function

Monday, 5th August, 1:45pm

Thomas Kryza

Development of theranostic agents for pancreatic ductal adenocarcinoma

Monday, 5th August, 1:45pm

Abirami Ratnasingham

Infant body composition predicts childhood obesity

Monday, 5th August, 1:45pm

Sahar Keshvari

IL-22-based therapies ameliorate hepatic steatosis associated with high-fat diet induced diabetes in mice

Monday, 5th August, 1:45pm

Ho Yi Wong

Laser dermabrasion: A potential preventative treatment for BCC recurrence

Monday, 5th August, 1:45pm

Johanna Erbani

Vascular niche E-selectin plays a key role in leukaemia chemoresistance

Monday, 5th August, 1:45pm

Nameer van Oosterom

Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity

Tuesday, 6th August, 10:45am

Jessica Whyte

DNA methylation is significantly different between Ankylosing spondylitis cases and healthy controls

Tuesday, 6th August, 10:45am

Liam O'Brien

Improving the efficacy of checkpoint inhibitors in a mouse model of melanoma

Tuesday, 6th August, 10:45am

Nicola Bray

 A 12-week multidisciplinary integrated treatment approach is superior to standard care for symptom improvement in functional gastrointestinal disorders (FGID) patients: a case-control study

Tuesday, 6th August, 10:45am

Priscila Oliveira de Lima

Establishing a novel preclinical model for perineural invasion of cutaneous SCCHN

Tuesday, 6th August, 10:45am

Rabina Giri

Harnessing Anti-inflammatory Gut Bioactives to Modulate the Immune Response in IBD

Tuesday, 6th August, 10:45am

 

Translational Relevance Prize Shortlist

The Translational Relevance Prize shortlist has now been released.  Presenters are required to present their poster in the usual poster sessions, and the highest scoring presenter on the Translational Relevence Prize Shortlist will be awarded in the Award Ceremony on Tuesday 6th of August.  All presenters are required to attend the Award Ceremony.

Guidelines and Categories for all Presentation types section of the website for more information

Presenter

Title

Category

Poster Number

Serena Ekman

Screening for novel monoclonal antibodies recognizing glycophorin b antigens via biopanning

Develop

7

Anne-Sophie Bergot

Islet-specific Liposomes Induced Diabetes Protection is Dependent on Islet-specific Regulatory T cells Reprogramming

Develop

9

Lisa Gillinder

Defining the clinical phenotype of neuronal autoantibody associated epilepsy

Discover

16

Kai Dun Tang

A “needleless” approach to detect HPV16-driven oropharyngeal cancer

Discover

17

Lucia Zacchi

Making better and cheaper drugs with mass spectrometry proteomics

Develop

18

Raymond Ho

Characterisation of Gaseous and Solid Embolic Pathlines During Cardiopulmonary Bypass: A Numerical and Invitro Study

Discover

58

Natali I Naude

Chemical deregulation in breast tissue of women at familial high risk correlates with IBIS risk calculator

Develop

59

Shannon Ryan

Building better science communicators

Deliver

77

Patrick Thomas

Detection of gonorrhoeae in prostate cancer tissues

Discover

91

Science Communication Prize

The theme for the 2019 Translational Research Symposium is SCIENCE COMMUNICATION: Talk SCIENCE to me.  Eight speakers will be given 5 minutes to present their work to the audience. Special guest judges aged 11-13, from four local schools will attend and vote for the talk they understand the best.  Presenters will need to be mindful of the audience. It is recommended speakers keep their presentation to approximately 5 slides.

Guidelines and Categories for all Presentation types section of the website for more information

The session will be held at 1:45pm - 2:45pm, Tuesday 6th August in the TRI Auditorium.

***Slides for this session need to be sent to [email protected] by 5pm, Thursday 1st August.***

Presenter

Title

Patricia Carreira

Role of Jumping Genes in Carcinomas

Candice Lee

Ubiquitous transgenic expression of IL-23 to mediate disease pathogenesis in spondyloarthritis

Ghazal Daraj

Human dendritic cell subsets produce Type III IFN in response to STING agonists

Patrick Thomas

Detection of gonorrhoeae in prostate cancer tissues

Anne-Sophie Bergot

Islet-specific Liposomes Induced Diabetes Protection is Dependent on Islet-specific Regulatory T cells Reprogramming

Eamonn McKenna

Integration of an ultra-strong biodegradable knitted mesh into a biodegradable porous structure for dermal tissue engineering

Ashley Meakin

Altered placental androgen signalling contributes to growth restricted outcomes

Ayaho Yamamoto

The airway epithelium: Oxidative stress and Cellular senescence

 

Two Minute Tease Presentations (Poster Presenters)

This year, poster presenters scoring high at Abstract Judging are offered the oppourtunity to present a two-minute-tease talk to advertise their poster presentation.  Talks will be 2 minutes, no question time, and the speaker will present their poster in the following poster session.

Guidelines and Categories for all Presentation types section of the website for more information

S1 - Session 1          9:00am - 9:30am

S2 - Session 2         12:00pm - 12:30pm

AUDITORIUM

***Slides for this session need to be sent to [email protected] by 5pm, Thursday 1st August.***

Presenter

Title

Category

Poster Number

Session

Charles Bidgood

High-content screening of small molecule inhibitors from the Australian biota targeting prostate cancer metabolism.

Discover

2

S1

Serena Ekman

Screening for novel monoclonal antibodies recognizing glycophorin b antigens via biopanning

Develop

7

S1

Lisa Gillinder

Defining the clinical phenotype of neuronal autoantibody associated epilepsy.

Discover

16

S1

Kai Dun Tang

A “needleless” approach to detect HPV16-driven oropharyngeal cancer.

Discover

17

S1

Lucia Zacchi

Making better and cheaper drugs with mass spectrometry proteomics

Develop

18

S1

Ben Vezina

Discovery of novel circular bacteriocins

Discover

29

S1

Nicola Warren

Anti-NMDAR encephalitis testing in psychiatry

Deliver

40

S1

Raymond Ho

Characterisation of Gaseous and Solid Embolic Pathlines During Cardiopulmonary Bypass: A Numerical and Invitro Study

Discover

58

S1

Natali I Naude

Chemical deregulation in breast tissue of women at familial high risk correlates with IBIS risk calculator

Develop

59

S1

Yassmin Musthaffa

Identification of patients with Type 1 Diabetes Suitable for Antigen-specific Tolerising Immunotherapy: T cell response to Pro-insulin peptides

Deliver

70

S2

Amelia Fotheringham

AGE and sRAGE regulation in response to increasing glucose loads in individuals with recently diagnosed type 2 diabetes

Discover

74

S2

Shannon Ryan

Building better science communicators

Deliver

77

S2

Kathy Luong (On behalf of Monica Ding)

Do consumers who identify as Muslim experience cultural sensitive care (CSC) in the Emergency Department (ED)? A scoping review

Deliver

90

S2

Andrew Jiang

Upscheduling decreases codeine-related presentations to a clinical toxicology unit

Deliver

93

S2

Tania Duarte

Deep Sequencing of Microbial Communities in Cystic Fibrosis Airways

Develop

100

S2

Sepideh Jahandideh

The Impact of Socio-environmental Factors on the Process of Engagement in Cardiac Rehabilitation Programs

Deliver

107

S2

Simon Thomas

Interpretable machine learning methods for the characterisation and classification of skin cancer

Deliver

108

S2

Poster Presentations

Each poster session is held over two rooms (2003/2004 and 2007).  Prizes will be announced after the keynote speakers at the end of the day.  

All Poster sessions will be held on Tuesday, 6th August

Guidelines and Categories for all Presentation types section of the website for more information

PS1 - Poster Session 1          9:30am - 10:45am

Room 2003/2004 - Posters 1 to 35
Room 2007 - Posters 36 to 59

***Set up anytime between 8:00am and 8:45am, Tuesday 6th August***

PS2 - Poster Session 2          12:30pm - 1:45pm

Room 2003/2004 - Posters 60 to 92
Room 2007 - Posters 93 to 113

***Set up anytime between 10:45am and 12:00pm, Tuesday 6th August***

PS3 - Poster Session 3            2:45pm - 4:00pm

Room 2003/2004 - Posters 114 to 143
Room 2007 - Posters 144 to 161

***Set up anytime between 12:30pm and 2:45pm, Tuesday 6th August***

Presenter

Title

Category

Poster Number

Session

Ghazaleh Hashemi

The role of endovascular progenitors in vessel formation in melanoma

Discover

1

PS1

Charles Bidgood

High-content screening of small molecule inhibitors from the Australian biota targeting prostate cancer metabolism.

Discover

2

PS1

Khawla Jaber

Improving safety measures during laser surgeries in the operating theatre

Develop

3

PS1

Faheem Maqbool

Production of Liposomes using supercritical fluid technology and active targeting of peptide to gastrin releasing peptide recept

Deliver

4

PS1

Nazanin Falconer

Prioritising hospital patients at high-risk of medication harm: development and validation of a predictive risk model

Develop

5

PS1

Stanimira Kartolova

Using the ieMR to compare presenting complaint, ED diagnosis and in patient diagnosis

Develop

6

PS1

Serena Ekman 

Screening for novel monoclonal antibodies recognizing glycophorin b antigens via biopanning

Develop

7

PS1

Michael MacDonald

Improving Pharmaceuticals Production in Cell Factories by Reducing Cell Death

Deliver

8

PS1

Anne-Sophie Bergot

Islet-specific Liposomes Induced Diabetes Protection is Dependent on Islet-specific Regulatory T cells Reprogramming

Develop

9

PS1

Candice Lee

Ubiquitous transgenic expression of IL-23 to mediate disease pathogenesis in spondyloarthritis

Discover

10

PS1

Zarqa Saif

A new glucocorticoid regulated placental mechanism that upregulates inflammation in small for gestational age babies

Discover

11

PS1

Madushan Fernando

AURKA overexpression overcomes the ATM dependent checkpoint in melanoma

Discover

12

PS1

Lynn Nazareth

Glial cells are important defenders against brain infection

Discover

13

PS1

Sau Fan (Eva) Liu

Use of Matlab programming in scientific research

Deliver

14

PS1

Achala Fernando

Functional characterisation of IRX4 transcript variants in prostate cancer pathogenesis

Discover

15

PS1

Lisa Gillinder

Defining the clinical phenotype of neuronal autoantibody associated epilepsy.

Discover

16

PS1

Kai Dun Tang

A “needleless” approach to detect HPV16-driven oropharyngeal cancer.

Discover

17

PS1

Lucia Zacchi

Making better and cheaper drugs with mass spectrometry proteomics

Develop

18

PS1

Sindusa Wignarajan

Major Trauma Response in the ED Resus at the Princess Alexandra Hospital

Deliver

19

PS1

Ramez Barsoum

A Multicentre Analysis of Hidradenitis Suppurativa (HS) Tissue Cultures

Deliver

20

PS1

Marzieh Negahban

Antimicrobial and cell viability effects of an indigenous plant.

Discover

21

PS1

Kerrin Watter

Reading deficits after brain injury: Developing an evidence-based approach

Develop

22

PS1

Saeid Alinezhad

Introduction of shRNA targeting androgen receptor inhibit tumour growth in prostate cancer patient-derived xenografts

Develop

23

PS1

Delaney Burnard

Comparative genomics and MIC testing of Australian Elizabethkingia isolates: discovering their diversity

Discover

24

PS1

Xi Zhang

A simple saliva test to identify Heart Failure patients as risk of adverse events

Deliver

25

PS1

Gayathri Thillaiyampalam

miR-34a-5p regulates immune checkpoint receptor PD-1 in natural killer cell activation against cancer cells

Discover

26

PS1

Ayaho Yamamoto

The airway epithelium: Oxidative stress and Cellular senescence

Discover

27

PS1

Ankit Shukla

Chromosome arm aneuploidies shape tumour evolution, cancer prognosis and precision oncology

Discover

28

PS1

Ben Vezina

Discovery of novel circular bacteriocins

Discover

29

PS1

Lena Batoon

Osteomacs promote regeneration after fracture and sustains bone homeostasis in osteoporotic bone

Discover

30

PS1

Mohammad Monzur Morshed

Kinetic expression of genes and receptors during monocyte to macrophage differentiation in cystic fibrosis

Discover

31

PS1

Annika Krueger

Staphylococcus aureus secreted proteins as local regulators of epithelial inflammation in photo-damaged skin

Discover

32

PS1

Sal Lee Goh

Direct Differentiation of Human Mesenchymal Stem Cells to Cholangiocyte Cells

Discover

33

PS1

Kavita Bisht

Erythropoiesis suppression by bacterial liposaccharides is extrinsically mediated independently of G-CSF

Discover

34

PS1

Angus Douglas (On behalf of Monica Ding)

A scoping review of patients’ perception of electronic medical record implementation in the emergency department

Deliver

35

PS1

Peiyu Wang

Cold Atmospheric Plasma Selectively Inhibits ‘Triple Negative’ Human Breast Cancer Cell Lines – Effects on EMP

Discover

36

PS1

Yu Hin Tang

Investigating the role of Neuropilin-1 in triple-negative breast cancer

Discover

37

PS1

Nathan Quigley

Current and novel diagnostic investigations applied simultaneously in a cohort of patients with suspected laryngopharyngeal reflux

Deliver

38

PS1

Darshan Shah

Endovascular thrombectomy in the real world: single center experience of PAH

Deliver

39

PS1

Nicola Warren

Anti-NMDAR encephalitis testing in psychiatry

Deliver

40

PS1

Ghazal Daraj

Human dendritic cell subsets produce Type III IFN in response to STING agonists

Discover

41

PS1

Tushar Kumeria

Porous Silicon Nanoparticles for Bioimaging

Develop

42

PS1

Samuel Kelly

Defining the diversity of conventional dendritic cells

Discover

43

PS1

Sara Hassan

Epithelial-mesenchymal plasticity in circulating tumour cells from metastatic patients and PDX models

Develop

44

PS1

Robert Ellis

A clinical tool to stratify risk of chronic kidney disease after surgical management of kidney cancer

Deliver

45

PS1

Juliana Müller Bark

Tracking pseudoprogression in glioblastoma patients using a liquid biopsy

Develop

46

PS1

Suganda Bhatia

Pooled shRNA library screening for doxorubicin, docetaxel and eribulin chemoresistance in MDA-MB-468 breast cancer cells

Discover

47

PS1

Leah Vegh

Physiotherapy “ICU Outreach” supports care of the deteriorating patient 

Deliver

48

PS1

Sara Motamen

Discovery of Ligand Structure-activity Relationship by Mass Spectrometry: Identification of New Tuberculosis Inhibitors

Discover

49

PS1

Xin Dong

Avoiding Voxel Contamination in 1H-MRS of the Human Kidney Cortex

Develop

50

PS1

Qiao Ding

The neuromuscular connection is impaired in amyotrophic lateral sclerosis

Develop

51

PS1

Natale Snape

Specific Antibody Response to Seasonal Influenza Vaccine in Chronic Obstructive Pulmonary Disease (COPD) and Healthy Older People.

Deliver

52

PS1

Phoebe Brandis

Treatment of Tremor at the Princess Alexandra Hospital with Gamma Knife Radiosurgery

Deliver

53

PS1

Ellen Tejo

Mysteries of Glycogen in the Periconceptional Ethanol-Exposed Placenta

Discover

54

PS1

Mei Zhou

Chronic stress-induced alterations in properties of adult-born hippocampal neurons directly regulate anxiety-related behaviours

Discover

55

PS1

Paria Saadat

Patient derived organoids of bladder cancer

Develop

56

PS1

Zeng Guo

Biochemical and Histopathological Differences between Posture-Responsive and Unresponsive Aldosterone-Producing Adenomas

Discover

57

PS1

Raymond Ho

Characterisation of Gaseous and Solid Embolic Pathlines During Cardiopulmonary Bypass: A Numerical and Invitro Study

Discover

58

PS1

Natali I Naude

Chemical deregulation in breast tissue of women at familial high risk correlates with IBIS risk calculator

Develop

59

PS1

Saeid Alinezhad

Enrichment and in vitro culture of circulating tumour cells from patients with gastro intestinal neuroendocrine carcinoma

Deliver

60

PS2

Nicola Warren

The role of psychiatry in management of anti-NMDAR encephalitis

Deliver

61

PS2

Madeleine Van Hunnik

Synchronizing Silos: Pathways to interconnected care with residential aged care facilities and acute hospitals settings

Develop

62

PS2

Burhan A. Khan

Increased bacterial burden in immunosuppressed organ transplant patients

Discover

63

PS2

Ji Yeon Kim

Photobiomodulation: the cellular and molecular mediators of a novel neuroprotective therapy

Develop

64

PS2

Denise Goh

Understanding the functions of exogenous IL-33 on dendritic cells in a HPV+ skin disease model

Discover

65

PS2

Jane Gifkins

A Qualitative Approach to the Impact of Shiftwork on Eating Patterns and Diet in Experienced and Inexperienced Nurses.

Deliver

66

PS2

Mischa Lundberg

Dissecting the genetic architecture of chronic pain using CTG-VL – Complex-Traits Genetics Virtual Lab

Develop

67

PS2

Semira Hailu

Identification of a Novel Target for Host-directed Therapy against Intracellular Pathogens

Discover

68

PS2

Jessica Turner

Intrapartum placental transfer of sildenafil citrate in term pregnancies

Develop

69

PS2

Yassmin Musthaffa

Identification of patients with Type 1 Diabetes Suitable for Antigen-specific Tolerising Immunotherapy

Discover

70

PS2

Sugarniya Subramaniam

Allele specific regulation of PDK1 by miRNAs in prostate cancer

Develop

71

PS2

Rachel Brimelow

Protocol to develop a mental health benchmarking tool for use in residential aged care settings

Develop

72

PS2

Tashbib Khan

Using ex vivo culture to bridge the gap between bench and bedside in ovarian cancer

Develop

73

PS2

Amelia Fotheringham

AGE and sRAGE regulation in response to increasing glucose loads in individuals with recently diagnosed type 2 diabetes

Discover

74

PS2

Ut Cheung

Targeting Mitochondrial Dysfunction in Diabetic Kidney Disease

Develop

75

PS2

Heather Batten

The relationship between gait speed, prosthetic potential and function in people with lower limb amputation

Deliver

76

PS2

Shannon Ryan

Building better science communicators

Deliver

77

PS2

Jemma Robb

Cold-water extraction of codine works...most of the time

Deliver

78

PS2

Shamima Banu Mohamed Ansari

The effectiveness of different methods of debriefing in reducing simulation-induced anxiety (SIA) within the Emergency Department (ED)

Deliver

79

PS2

Xiaoyu Hou

Immunotherapy of Established HPV-associated Cancers by Combination of Immunomaterial Technology and E7 Long Peptide Vaccines

Develop

80

PS2

Rizwana Afroz

Bacterial lipopolysaccharide stimulates glycosaminoglycan chain elongation: the link between infection and atherosclerosis

Discover

81

PS2

Srilakshmi Srinivasan

A functional PSA prostate cancer susceptibility genetic variant confers both reduced and aggressive cancer risk

Discover

82

PS2

Asmerom Sengal

Mesenchymal splice isoform Fibroblast Growth Factor Receptor (FGFR2c) is an independent prognostic biomarker and further refines risk stratification within endometrial cancer molecular subtypes

Develop

83

PS2

Raymond Quan

Burn Wound Progression: A Histological Analysis of the Mechanisms Responsible

Discover

84

PS2

Md Anayet Hasan

Non-genotoxic conditioning facilitates tolerance induction through stable mixed hematopoietic chimerism of gene modified BM

Discover

85

PS2

Julia Watson

Monitoring Acute Low Back Pain using 2D Correlated Spectroscopy of the Brain at 3T: A Case Study

Develop

86

PS2

David Highton

Impact of anaesthetic technique on stroke outcome treated with endovascular therapy.

Deliver

87

PS2

Ramez Barsoum

Clinical Dermatology Photography and Patient Consent: The Princess Alexandra Experience

Deliver

88

PS2

Aihua (Nicole)  Wu

Administration of exogenous mineralocorticoids and potassium is associated with a reduction in pendrin abundance in urinary exosomes from patients with primary aldosteronism

Deliver

89

PS2

Kathy Luong (On behalf of Monica Ding)

Do consumers who identify as Muslim experience cultural sensitive care (CSC) in the Emergency Department (ED)? A scoping review

Deliver

90

PS2

Patrick Thomas

Detection of gonorrhoeae in prostate cancer tissues

Discover

91

PS2

Joanna Kapeleris

Ex-vivo culture of airway cancer derived circulating tumour cells for precision medicine

Discover

92

PS2

Andrew Jiang

Upscheduling decreases codeine-related presentations to a clinical toxicology unit

Deliver

93

PS2

Adil Malik

The long and short of GWAS Associated long non coding RNA

Discover

94

PS2

Urmita Jhaveri

Sodium-Glucose Cotransporter-2 Inhibitors and Euglycaemic Diabetic Ketoacidosis in the Perioperative Period: Case Report

Deliver

95

PS2

Shubhra Chandra

Delineating the role of Hepatocyte Nuclear Factor 1 Beta (HNF1B) in prostate cancer

Discover

96

PS2

Selena Le Bagge

Advanced Glycation End Products as Predictors of Renal Function in Young People with Type1 Diabetes

Develop

97

PS2

Farhad Dehkhoda

Mechanism of GP130 activation and regulation of its downstream signalling

Discover

98

PS2

Moustafa Sherif

Genetically engineered monocytes: a new strategy to improve the outcome of immunotherapies in metastatic breast cancer

Deliver

99

PS2

Tania Duarte

Deep Sequencing of Microbial Communities in Cystic Fibrosis Airways

Develop

100

PS2

A K M Mahmudul Haque

Targeting adaptive response in advance prostate cancer with combined anti-androgen and biguanide treatment.

Develop

101

PS2

Serena Ekman

In Silico Model For Extracellular Glycophorin A (GPA) Structure

Discover

102

PS2

Chamikara Liyanage

Identification and characterization of micropeptides involved in adaptive response to androgen deprivation therapy

Discover

103

PS2

Marguerite Kutyla

In-Vitro Evaluation of Antifoaming Effects of Simethicone: A Dose-Finding-Study

Deliver

104

PS2

Rose Ann G. Franco

Guided In Vitro Chondrogenesis of Bone Marrow-derived Stromal Cells using small molecules

Develop

105

PS2

Lena Oestreich

Neuroimaging biomarkers for early detection of post-stroke depression

Discover

106

PS2

Sepideh Jahandideh

The Impact of Socio-environmental Factors on the Process of Engagement in Cardiac Rehabilitation Programs

Deliver

107

PS2

Simon Thomas

Interpretable machine learning methods for the characterisation and classification of skin cancer

Deliver

108

PS2

Ryan J. Hall

Studying the structures of proteins that control cellular transport using X-ray crystallography.

Discover

109

PS2

Raji Baidya

TRIF- RIPK3-MLKL mediated necroptosis contributes to ischaemia induced cell death in steatotic hepatocytes

Discover

110

PS2

Weidong Gao

The enhancement of therapeutic protein-drug production by 3D printed carrier in bioreactor culture system

Develop

111

PS2

Colin (Qiang) Cheng

A novel companion blood test to personalize Natalizumab treatment regime

Develop

112

PS2

Mitchell Robinson

The use of reflectance confocal microscopy in clinical practice to diagnose basal cell carcinomas: A cost benefit analysis

Deliver

113

PS2

Jackie Creagh

The Yin-Yang model of IL-23p19/IL-23∆9: A potential therapeutic target for Inflammatory Bowel Disease

Discover

114

PS3

Erin Kelly

Improving services for patients with Disorders of Consciousness (DOC): Implementation of family and staff education packages in a Neurosciences Unit

Deliver

115

PS3

Md Saiful Islam Roney

Novel autoantibody profiling in the discovery of colorectal cancer biomarkers

Discover

116

PS3

Rainbow Lai

A Stroke Nutrition and Hydration Pathway Enhances Enteral Nutrition Outcomes

Deliver

117

PS3

Md. Moniruzzaman

Divergent roles of interleukin-20 family cytokines in controlling intestinal inflammation

Discover

118

PS3

Emma Morton

Outcomes for Patients Presenting to the Princess Alexandra Hospital (PAH) Emergency Department (ED) Following Out of Hospital Cardiac Arrest (OHCA).

Deliver

119

PS3

James Dight

Endovascular progenitors initiate and drive de novo vascularisation in melanoma

Discover

120

PS3

Aihua (Nicole) Wu

Effects of acute Na+ loading on NCC abundance and phosphorylation in urinary exosomes from hypertensives with a raised aldosterone to renin ratio (ARR)

Discover

121

PS3

Mandy Nielsen

Early Action Appraised: Stakeholders’ perspectives on early pilot ABI transitional rehabilitation

Deliver

122

PS3

Bing Sun

Development of Nanoparticle Platforms for Targeted Delivery and Immune Enhancement of Nucleic Acid Vaccines

Deliver

123

PS3

Amelia Katherine Fotheringham

Using the geometric framework for nutrition to understand the influence of macronutrient intake on the kidney.

Deliver

124

PS3

Amy Johnston

Better simulation by design: A best-practice in simulation framework

Deliver

125

PS3

Nicola Bray

Functional gastrointestinal disorders (FGIDS) patients benefit from a 12-week multidisciplinary integrated treatment approach to reduce anxiety and depressive symptoms.

Deliver

126

PS3

Yuao Wu

Novel nanotechnology approach for diagnosis and treatment of cardiovascular disease

Develop

127

PS3

Shayna Sharma

Utilisation of Exosomal miRNAs and Proteins for Identification of Early Stage Epithelial Ovarian Cancer

Develop

128

PS3

Sharene Chong

Melanoma patient survival: Prognostic value of pSTAT5 as a biomarker

Deliver

129

PS3

Mitchell Robinson

Reflectance Confocal Microscopy: Non-invasive diagnosis of skin cancer at the Princess Alexandra Hospital

Deliver

130

PS3

Khawla Jaber

Introducing flashing lights in laser theatre

Deliver

131

PS3

Huynh Nguyen

Low Dose of Gamma Irradiation Does Not Affect Mechanical Properties of Tendon Allograft

Deliver

132

PS3

Sumia Essid

Proinsulin C-Peptide Enhances Cell Survival and Protects against Simvastatin-Induced Myotoxicity in L6 Rat Myoblasts

Discover

133

PS3

Urmita Jhaveri

Integration of contemporary CT Coronary Angiography in care of patients suspected to have Takotsubo Cardiomyopathy

Deliver

134

PS3

Xuan Huang

Syndecan expression levels in high vs low mammographically dense human breast tissue

Deliver

135

PS3

Michelle Edmonds

The phosphate debate: intravenous vs Oral

Deliver

136

PS3

Ritu Shrestha

TNF-α promotes epithelial-to-mesenchymal transition and expression of immune checkpoint molecules in hepatocellular carcinoma

Discover

137

PS3

Ashley Meakin

Altered placental androgen signalling contributes to growth restricted outcomes

Discover

138

PS3

Zachariah Schuurs

Elucidating functional relationships through electrostatic characterisation of proteins with an oligosaccharide/oligonucleotide

Discover

139

PS3

Cameron Haigh

Musical Attention Control Training in adult mental health rehabilitation

Deliver

140

PS3

M. Madusha Nuwanthi Perera

Antimicrobial effects of an Australian native plant against common wound-colonising bacteria.

Discover

141

PS3

Ying Zhou

LPA receptor mediated TGFBR1 transactivation stimulates the expression of GAG synthesizing genes

Discover

142

PS3

Amy Johnston

Evidence of the effectiveness of multidisciplinary simulation training in disaster management; a case study

Deliver

143

PS3

Abirami Ratnasingham

Infant body composition predicts childhood obesity

Develop

144

PS3

Jilai Zhao

EndoVascular Progenitor function in atherosclerosis

Develop

145

PS3

Eamonn McKenna

Integration of an ultra-strong biodegradable knitted mesh into a biodegradable porous structure for dermal tissue engineering

Develop

146

PS3

Johan Medina Benavente

H2-Bl/HLA-G as a regulator of the inflammatory process following partial hepatectomy.

Develop

147

PS3

Amy Johnston

Making our EDs ‘sharps safe’; Understanding staff attitudes and current use of sharp safety devices

Develop

148

PS3

Aparna Arjunan

Predicting adverse outcomes in geriatric rehabilitation

Develop

149

PS3

Melanie Caruso

Analysis of the impact of Colony Stimulating Factor (CSF1) administration in adult rats using a novel Csf1r-mApple reporter gene

Discover

150

PS3

Kaylyn Tousignant

Extensive lipid remodelling fuelled by lipid uptake is an early mechanism of resistance to androgen receptor-targeted therapies in prostate cancer

Discover

151

PS3

Sai Praneeth Narla

Effect of Human Rhinovirus on Immune checkpoint expression.

Discover

152

PS3

Saeid Alinezhad

Precision medicine in the management of men with early biochemically recurrent prostate cancer using a novel in vitro approach

Deliver

153

PS3

Ramez Barsoum

Surgical Outcomes in Hidradenitis Suppurativa: A Novel Multidisciplinary Approach

Deliver

154

PS3

Patricia Carreira

Role of Jumping Genes in Carcinomas

Discover

155

PS3

Estelle Jensen

Patient Flow at PAH Improved by Transit Care Hub Pharmacist

Deliver

156

PS3

Jessica Rankine

Rituximab- minimal dose for Minimal Change

Deliver

157

PS3

Mandy Nielsen

Interdisciplinary goal planning in early rehabilitation: Exploring three different techniques

Deliver

158

PS3

Nicola Warren

Challenges and solutions for the development of online, interactive psychiatric education

Develop

159

PS3

Xiaoling Hu (Presented by Sal Lee Goh)

Increasing perfluorooctane sulfonate renal elimination using transporter inhibitors

Develop

160

PS3

Ingrid Hickman (On behalf of Heidi Johnston)

The feasibility and acceptabiliy of sarcopenia assessments of liver transplant candidates.

Develop

161

PS3

Guidelines and Categories for all Presentation types

CATEGORIES FOR POSTER PRESENTATIONS

DISCOVER

Investigate the what, why and how behind biological processes through fundamental research and proof of concept work

DEVELOP

Improve and design treatments, technologies, detection and delivery systems that would enable the fundamental research to be translated into a pre-clinical setting

DELIVER

Optimize and commercialize diagnosis, prognosis and treatments of preventative approaches in the clinical setting

 

Oral Presentation Guidelines

  • ***Slides for this session need to be sent to [email protected] by 5pm, Thursday 1st August.***
  • Held in the Auditorium
  • 8 Minutes with 2 minute questions
  • Bell will ring at 7 minutes, Chair will stand at 8 minutes and the talk immediately stopped for question time. 
  • Videos and audio are allowed.
  • Prize Money for oral presenters is Winner $1000, Runner Up $500.

Poster Presentation Guidelines

  • Held in the 2003/2004 and 2007 poster halls.
  • The poster must be A0 size (A0 size is 841mm x 1189mm) in portrait orientation
  • It is recommended that font below size 24 is not to be used.  
  • Presenter must remain at their poster, otherwise judge will award a mark of ZERO
  • Prize Money for poster presenters is Winner $250, Runner Up $150.

PS1 - Poster Session 1          9:30am - 10:45am

Room 2003/2004 - Posters 1 to 35
Room 2007 - Posters 36 to 59

***Set up anytime between 8:00am and 8:45am, Tuesday 6th August***

PS2 - Poster Session 2          12:30pm - 1:45pm

Room 2003/2004 - Posters 60 to 92
Room 2007 - Posters 93 to 113

***Set up anytime between 10:45am and 12:00pm, Tuesday 6th August***

PS3 - Poster Session 3            2:45pm - 4:00pm

Room 2003/2004 - Posters 114 to 143
Room 2007 - Posters 144 to 161

***Set up anytime between 12:30pm and 2:45pm, Tuesday 6th August***

Poster and Two Minute Tease Presentation Guidelines

  • ***Slides for this session need to be sent to [email protected] by 5pm, Thursday 1st August.***
  • Two minute Tease talks held in the AUDITORIUM followed by poster to be judged along side regular poster presentations.
  • Two Minute Tease talks are not judged.
  • Two minute Tease talks are strictly 2 minutes, with no question time.
  • The poster must be A0 size (A0 size is 841mm x 1189mm) in portrait orientation.  
  • It is recommended that font below size 24 is not to be used.  
  • Presenter must remain at their poster, otherwise judge will award a mark of ZERO
  • You only have 2 minutes, keep number of slides to a minimum
  • Videos and audio are allowed.
  • Prize Money for poster presenters is Winner $250, Runner Up $150.

Science Communication Talk Guidelines

  • ***Slides for this session need to be sent to [email protected] by 5pm, Thursday 1st August.***
  • Held in the Auditorium
  • 5 Minutes, no question time
  • Bell will ring at 4 minutes, Chair will stand at 5 minutes and the talk immediately stopped.
  • It is recommended that speakers use no more than 5 slides, this is not enforced. 
  • Videos and audio are allowed.
  • Total Prize Money $500.

Translational Relevance Prize Guidelines

  • Shortlist of 10 Presenters compete for the highest poster score.
  • Poster presentations to be given in usual poster sessions.
  • Translational Relevance Prize will be awarded to the highest score.
  • Total prize money of $250.

Frequently Asked Questions

Where is the closest bus and train stop to TRI?
I am not submitting an abstract this year.  Can I still attend?
Who can submit an abstract?
Do I need to register as well if I submit an abstract?
What if I’m not sure which category to enter in?
Do I need to be with my poster during the poster session?
What is a translational aspect?

Where is the closest bus and train stop to TRI?

The closest bus station is the PA hospital stop, once you are off the bus, walk up the hill of Diamantina Rd to the large orange building, TRI.  The closest train station is Dutton Park train station, continue walking down Kent St and you can follow the orange path to the atrium of the TRI building.

I am not submitting an abstract this year.  Can I still attend?

Absolutely!  We hope to see you there.  Make sure you register when registrations open.  They will open in late June after the results of abstract judging are released.

Who can submit an abstract?

Abstract Submissions are now CLOSED.  We open abstract submissions to all students (honours, masters and PhD), as well as anyone conducting translational research.  This includes research assistants, early career researchers (ECRs), mid-career researchers (MCRs), and clinicians.  We welcome anyone from the South-East Queensland region to submit abstracts and attend the symposium.

Do I need to register as well if I submit an abstract?

Yes.  Submitting an abstract is separate to registration.  Despite being a free event, we require registration to determine the numbers for catering, and food requirements.  Also by registering, you will be able to receive your free beverage from the coffee cart.  Registrations will open shortly after abstract submissions close and presenters announced, and a reminder email to register will be sent out to poster and oral presenters.  You must register to present at the TRS.

What if I’m not sure which category to enter in?

If you are unsure as to what category to enter under, please email [email protected] with the subject line ‘TRS-2019 Category’ with your abstract and we will let you know.  You will then need to return to the submissions page and enter your abstract. 

Do I need to be with my poster during the poster session?

To be eligible for poster prizes, you must be at your poster during the poster session.  Judges will make a maximum of two visits to your poster before awarding you ZERO.

What is a translational aspect?

A fundamental or basic science project is the systematic study towards a greater knowledge, or understanding.  A TRANSLATIONAL project is addressing a clinical question with information that may help improve a treatment, or care of patients.

The 2019 Sponsors

Thankyou to our 2019 Sponsors.  

At TRS, the trade display passport allows attendees to win a prize – make sure you visit our sponsors on the day and check out their websites!

There will be 13 lucky door prizes up for grabs thanks to our Platinum and Gold Sponsors!

 
 

PLATINUM

PATHTECH

 

GOLD

LAB CABS

GENESEARCH

AUSTRSLIAN BIOSEARCH

CORNING

LAB GEAR

LONZA

TRANSNETYX

BIOSTRATEGY

EPPENDORF

MILTENYI BIOTEC

SARSTEDT

MICROBA

SILVER

MP BIOMEDICALS

LABTEK

JOHN MORRIS

IDT

BIOTOOLS

ANDI-CO/LIEBHERR

TRENDBIO

THERMOFISHER SCIENTIFIC

WORLD COURIER

BRONZE

BANKSIA SCIENTIFIC

AUSTRALIAN GENOME RESEARCH FACILITY

TECAN

BIORAD

IN VITRO